OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases
Congjian Shi, Hongqin Yang, Zhenghong Zhang
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
Tobias Puengel, Hanyang Liu, Adrien Guillot, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2668-2668
Open Access | Times Cited: 73

Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
Ya-Shuo Feng, Zixuan Tan, Manman Wang, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 76

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
Sonia Missiroli, Mariasole Perrone, Caterina Boncompagni, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 67

Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway
Yanfang Deng, Qianqian Xu, Tianqi Chen, et al.
Phytomedicine (2022) Vol. 104, pp. 154241-154241
Closed Access | Times Cited: 32

Mechanisms of immunity in acutely decompensated cirrhosis and acute‐on‐chronic liver failure
Cornelius Engelmann, Ingrid W. Zhang, J. J. Clariá
Liver International (2023)
Open Access | Times Cited: 16

Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus
Wei Tan, Zhifeng Gu, Junling Leng, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109313-109313
Open Access | Times Cited: 43

Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis
Seyeon Oh, Myeongjoo Son, Kyung-A Byun, et al.
Marine Drugs (2021) Vol. 19, Iss. 6, pp. 318-318
Open Access | Times Cited: 37

Inflammation and gut microbiota in the alcoholic liver disease
Yan Gao
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420020-9420020
Closed Access | Times Cited: 4

The Emerging Relevance of AIM2 in Liver Disease
Beatriz Lozano‐Ruiz, José M. González‐Navajas
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6535-6535
Open Access | Times Cited: 38

Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice
Yuanqiang Zhang, Jing Wen, Dongqing Liu, et al.
Life Sciences (2021) Vol. 281, pp. 119778-119778
Closed Access | Times Cited: 27

Green tea polyphenols mitigate the plant lectins-induced liver inflammation and immunological reaction in C57BL/6 mice via NLRP3 and Nrf2 signaling pathways
Dongxu Wang, Man Zhang, Taotao Wang, et al.
Food and Chemical Toxicology (2020) Vol. 144, pp. 111576-111576
Closed Access | Times Cited: 27

Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome
Weixiao Niu, Yunyang Bao, Na Zhang, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105971-105971
Closed Access | Times Cited: 15

NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
Sara F. Awwad, Raymonde Assaf, Ahmed A. Emam, et al.
Medical Oncology (2023) Vol. 40, Iss. 3
Open Access | Times Cited: 7

Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway
Yuanyuan Wu, Jingwen Zhou, Xinchen Zuo, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 3, pp. 224-234
Closed Access | Times Cited: 2

The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors
Yang Yang, Liangliang Bai, Wei‐Ting Liao, et al.
Experimental Cell Research (2021) Vol. 405, Iss. 2, pp. 112678-112678
Closed Access | Times Cited: 15

Polysaccharide of Atractylodes macrocephala Koidz alleviate lipopolysaccharide-stimulated liver inflammation injury of goslings through miR-223/NLRP3 axis
Feiyue Chen, Bingxin Li, Wanyan Li, et al.
Poultry Science (2022) Vol. 102, Iss. 1, pp. 102285-102285
Open Access | Times Cited: 10

Suppression of inflammatory cascades via novel cinnamic acid nanoparticles in acute hepatitis rat model
Ehab A. Ibrahim, Fatma S. M. Moawed, Enas M. Moustafa
Archives of Biochemistry and Biophysics (2020) Vol. 696, pp. 108658-108658
Closed Access | Times Cited: 15

Inflammasome as an Effective Platform for Fibrosis Therapy
Tingting Chen, Feng Xiao, Nan Li, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1575-1590
Open Access | Times Cited: 12

β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats
Huijuan Luo, Nan Xu, Jiazhen Wu, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107915-107915
Closed Access | Times Cited: 7

Mechanism of miR-126 in hypoxia-reoxygenation-induced cardiomyocyte pyroptosis by regulating HMGB1 and NLRP3 inflammasome
Fei Ling, Ning Zhang, Jun Zhang
Immunopharmacology and Immunotoxicology (2022) Vol. 44, Iss. 4, pp. 500-509
Closed Access | Times Cited: 5

Kauranes as Anti-inflammatory and Immunomodulatory Agents: An Overview of In Vitro and In Vivo Effects
Michael R. Mijares, Gricelis Martínez, Juan Bautista De Sanctis
(2022), pp. 191-239
Closed Access | Times Cited: 4

Charnolosome nanotheranostics in autoimmune diseases
Sushil Sharma
Elsevier eBooks (2024), pp. 615-631
Closed Access

Charnolosome nanotheranostics in inflammatory diseases
Sushil Sharma
Elsevier eBooks (2024), pp. 595-613
Closed Access

Charnolosome nanotheranostics in metabolic diseases
Sushil Sharma
Elsevier eBooks (2024), pp. 251-261
Closed Access

Page 1 - Next Page

Scroll to top